Featured Research

from universities, journals, and other organizations

Oncology: A 'Neu' Protein Target In The Treatment Of Breast Cancers

Date:
December 15, 2007
Source:
Journal of Clinical Investigation
Summary:
Overexpression of the protein EphA2 in aggressive breast cancer is common, and generally leads to poor outcome for the patient. However, the function of Eph2A in cancer progression is controversial, with conflicting evidence suggesting both pro- and anti-cancer roles for the protein. Scientists have now presented evidence that the role Eph2A in breast cancer is highly context dependent.

Overexpression of the protein EphA2 in aggressive breast cancer is common, and generally leads to poor outcome for the patient. However, the function of Eph2A in cancer progression is controversial, with conflicting evidence suggesting both pro- and anti-cancer roles for the protein.

In a new study, Jin Chen and colleagues from Vanderbilt University School of Medicine, Nashville, have presented evidence that the role Eph2A in breast cancer is highly context dependent.

EphA2 expression was eliminated in two different mouse models of breast cancer that mimic the progression of human tumors through the various stages. MMTV-Neu is a mouse model for overexpression of NEU, a cancer-causing gene (oncogene) that is overexpressed in about 30% of human breast cancer cases.

In contrast, the MMTV--PyV-mT mouse models multistep progression of human breast cancers by activation of a number of oncogenes. The researchers found that EphA2 deficiency in MMTV-Neu mice impaired both the initiation of tumor growth and the progression of metastasis.

Further analysis of mouse cells revealed that the presence of EphA2 enhanced tumor growth and movement by binding Neu. In addition, treatment of MMTV-Neu mice with an anti-EphA2 therapy reduced tumor volume. In contrast, EphA2 deletion had no noticeable effect on cancer progression in the MMTV-PyV-mT mice.

The authors therefore concluded that EphA2 interacts with Neu to enhance tumor progression, and might be a novel target for treating individuals with tumors dependent on Neu signaling.

Journal article: The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. Journal of Clinical Investigation. Dec 13, 2007.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Oncology: A 'Neu' Protein Target In The Treatment Of Breast Cancers." ScienceDaily. ScienceDaily, 15 December 2007. <www.sciencedaily.com/releases/2007/12/071214201052.htm>.
Journal of Clinical Investigation. (2007, December 15). Oncology: A 'Neu' Protein Target In The Treatment Of Breast Cancers. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2007/12/071214201052.htm
Journal of Clinical Investigation. "Oncology: A 'Neu' Protein Target In The Treatment Of Breast Cancers." ScienceDaily. www.sciencedaily.com/releases/2007/12/071214201052.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins